Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05003167 · ClinicalTrials.gov registry record · NA
Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05003167 is a NA study that has completed, run by Purdue University. The registered enrollment target is 13 participants.
The verdict
NCT05003167, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
A tele-health treatment study for individuals with early stage ALS with the aim to improve communication, cough response, and respiratory strength. All participants complete a respiratory strength training program using an Expiratory Muscle Strength Training (EMST 150) device from the comfort of their homes for 6 weeks.
Interventions
- DEVICE Expiratory Muscle Strength Training (EMST-150)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05003167
The ClinicalTrials.gov registry entry for NCT05003167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Expiratory Muscle Strength Training (EMST-150) is the first listed.
NCT05003167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05003167 about?
NCT05003167 is a clinical study titled "Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS". A tele-health treatment study for individuals with early stage ALS with the aim to improve communication, cough response, and respiratory strength. All participants complete a respiratory strength training program using an Expiratory Muscle Strength Training (EMST 150) device from the comfort of the...
What is the current status of trial NCT05003167?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2021-01-01. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT05003167?
The interventions under investigation include: Expiratory Muscle Strength Training (EMST-150) (DEVICE).
Who is sponsoring clinical trial NCT05003167?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.